BHCM
GH icon

Brevan Howard Capital Management’s Guardant Health GH Stock Holding History

Brevan Howard Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.95M Buy
+19,677
New +$2.14M 0.02% 558
2024
Q4 		– Sell
-11,757
Closed -$270K – 1193
2024
Q3 		$270K Buy
+11,757
New +$333K ﹤0.01% 894

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Brevan Howard Capital Management's GH Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Guardant Health (GH) in Q2 2026: 19,677 shares worth $2.95M. The stake represents 0.02% of the portfolio and ranks #558 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in GH as recently as Q3 2024.

Brevan Howard Capital Management first reported a position in GH in Q3 2024 and has held it in 2 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Brevan Howard Capital Management held 19,677 shares of Guardant Health worth $2.95M as of Q2 2026.
  • Guardant Health was a new Brevan Howard Capital Management position in Q2 2026.
  • Guardant Health made up 0.02% of Brevan Howard Capital Management's portfolio in Q2 2026, its #558 holding.
  • Brevan Howard Capital Management first reported a position in Guardant Health in Q3 2024 and has held it in 2 quarters since.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.